BioNexus Gene Lab Corp is a MY-based company operating in Trading Companies & Distributors industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2020-03-11. BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The firm provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The firm operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis, which the Company uses in its business. The firm's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the potential risk of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in the Asean region.
Follow-Up Questions
What is the price performance of BGLC stock?
The current price of BGLC is $5.5, it has decreased 3.5% in the last trading day.
What are the primary business themes or industries for BioNexus Gene Lab Corp?
BioNexus Gene Lab Corp belongs to Trading Companies & Distributors industry and the sector is Industrials
What is BioNexus Gene Lab Corp market cap?
BioNexus Gene Lab Corp's current market cap is $9.9M
